| Literature DB >> 27578372 |
Hong-Bo Zhang1, Tian-Long Xing, Rui-Xue Yin, Yong Shi, Shi-Mo Yang, Wen-Jun Zhang.
Abstract
In this review, we focused on a few obstacles that hinder three-dimensional (3D) bioprinting process in tissue engineering. One of the obstacles is the bioinks used to deliver cells. Hydrogels are the most widely used bioink materials; however, they aremechanically weak in nature and cannot meet the requirements for supporting structures, especially when the tissues, such as cartilage, require extracellular matrix to be mechanically strong. Secondly and more importantly, tissue regeneration is not only about building all the components in a way that mimics the structures of living tissues, but also about how to make the constructs function normally in the long term. One of the key issues is sufficient nutrient and oxygen supply to the engineered living constructs. The other is to coordinate the interplays between cells, bioactive agents and extracellular matrix in a natural way. This article reviews the approaches to improve the mechanical strength of hydrogels and their suitability for 3D bioprinting; moreover, the key issues of multiple cell lines coprinting with multiple growth factors, vascularization within engineered living constructs etc. were also reviewed.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27578372 PMCID: PMC4992174 DOI: 10.1016/j.cjtee.2016.06.007
Source DB: PubMed Journal: Chin J Traumatol ISSN: 1008-1275
Literature review of living constructs by 3D bioprinting.
| Materials | Crosslinking | Mechanical strength | Printing system and parameters | Cell viability | Application |
|---|---|---|---|---|---|
| Thiol-HA and Gelatin | Two stages: PEGDA (30 min) and PEG-alkyne UV crosslinking (2–4 s) | Shear elastic modulus G′ of 15–20 kPa (similar to native liver tissue) | In-house design; Extrusion-based bioprinting with 20–30 gauge needle | Albumin and urea productions over 14 d were confirmed | Liver spheroids |
| Nanocellulose-Alginate | Ionically-crosslinked (10 min) | Compress stiffness of 70–240 kPa | Microvalve dispenser; Needle size of 300 μm; dispensing pressure of 20–60 kPa; dosing distance of 50–70 μm | Human nasoseptal chondrocytes; Cell viability was 72.8% at 1 d after printing | Cartilage |
| Silk Gelatin | Tyrosinase and sonification | Unspecified | Height of each layer and printing temperature were optimized; Temperature of the syringe barrel was maintained at 28 °C and the printing chamber was maintained at 18 °C | Stem cells chodrocytes and osteocytes density was 2 × 106–5 × 106 cells/ml; Cell viability was 96% at 1 d after printing and 87% upto 30 d | Bone and cartilage |
| Alginate | Ionically-crosslinked with CaCl2 and barium chloride | Stiffness of 20 kPa | Nozzle ID of 0.33–0.45 mm; Printing speed of 0.45 ml/min and 0.65 ml/min | U87-MG cells at 2 × 106 cells/ml; Cell viabilities were 61.5%–93% at different crosslinking densities (88% at 1 d) | Unspecified |
| Gelatin methacrylamide | Photocrosslinking withVA-086 (UV-A light, 365 nm, 4 mW/cm2) | Unspecified | Pressure at 0.5–4 bar | Hepatocarcinoma cell line; Viability was 98% at printing pressure of 0.5 bar; Albumin, HNF4a, Ki67 and PCNA expression was confirmed. | Liver |
| GelMA PEGDA | UV crosslinking GelMA and PEGDA 4.8 mW/cm2 (2 min) | Elastic modulus: 5 kPa | Digital micromirror device projection printing | Fibroblasts; Viability was 80% after 10 d | Unspecified |
| Alginate/HA | Ionically-crosslinked with EDC | Unspecified | Envision TEC 3D-bioplotter | Schwann cells | Unspecified |
| PU NPs PCL based | Thermal response amphiphilic PU gel | Young's modulus: 15–157 MPa | The syringe diameter was 260 μm; gas pressure was 241–275 kPa, and the volume flow rate was 1.67 μl/min | MSCs; Viability was 100% after printing and 40% after 1 d | Unspecified |
| PU NPs PCL based | Thermal response at 37° | G′: 680–2400 Pa | Nozzle of 250 μm and pressure of 55 kPa; In house build printing system | Neural stem cells | Unspecified |
| Collagen | Crosslinked with NaHCO3 | Unspecified | Droplet dispersion pressure at 1–3 psi; In house microvalve system | Keratinocytes and Fibroblasts | Skin |
| PEGX-gelatin PEGX-Fibrin | Crosslinked with EDC/NHS and UV light at the intensity of 15–20 mW/cm2 (10 min) | G′: 4–23 Pa | Diameter nozzles of 200 μm; Envision TEC 3D-bioplotter; Pressure of 1–2.5 bar; Speed of 5 mm/s | Human umbilical vein endothelial cells, Human dermal fibroblasts and Human mesenchymal stem cells | Tissue and organ mimics |
| GelaMA/Melt espining PCL | GelMA APS/TENED | Stiffness of hydrogel: 7.1–15.8 kPa, after incorporated with PCL:405 kPa | PCL was extruded at a rate of 18 μl/h; Electrostatic field of 8–10 kV between the syringe needle tip (23G); BioScaffolder system | Chondrocytes cell viability was 82% at 1 d and 75% at 7 d | Cartilage |
| Glycosaminoglycans (GAGs) | Ethylene glycol dimethacrylate as crosslinker pre-crosslinked; Photoinitiating system composed of eosin Y, triethanolamine and N-vinylpyrrolidone (visible laser light: 514 nm, 500 mW/cm2) | Compressive stiffness: 0.78 MPa | Cylindrical bovine osteochondral explants (7 mm in diameter) | Articular cartilage | Cartilage |
Fig. 1PCL strands support cell-embedded alginate constructs. Figure has been reproduced with permission from Yeo.